Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-21-003994
Filing Date
2021-03-31
Accepted
2021-03-30 17:33:02
Documents
18

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2038571
2 GRAPHIC g120909g00c28.jpg GRAPHIC 164764
3 GRAPHIC g120909g09b98.jpg GRAPHIC 87570
4 GRAPHIC g120909g20d72.jpg GRAPHIC 138839
5 GRAPHIC g120909g42p28.jpg GRAPHIC 158320
6 GRAPHIC g120909g55l82.jpg GRAPHIC 84880
7 GRAPHIC g120909g66n88.jpg GRAPHIC 63110
8 GRAPHIC g120909g72x04.jpg GRAPHIC 107407
9 GRAPHIC g120909g73x08.jpg GRAPHIC 129953
10 GRAPHIC g120909g74c58.jpg GRAPHIC 110776
11 GRAPHIC g120909g77p33.jpg GRAPHIC 106199
12 GRAPHIC g120909g78g60.jpg GRAPHIC 144378
13 GRAPHIC g120909g84o72.jpg GRAPHIC 164580
14 GRAPHIC g120909g94h61.jpg GRAPHIC 128040
15 GRAPHIC g120909g96s82.jpg GRAPHIC 96552
16 GRAPHIC g120909g98k04.jpg GRAPHIC 97684
17 GRAPHIC g120909g99c98.jpg GRAPHIC 142793
18 GRAPHIC g120909g99i99.jpg GRAPHIC 83073
  Complete submission text file 0000950123-21-003994.txt   4753392
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Filer) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-04235 | Film No.: 21788455
SIC: 2836 Biological Products, (No Diagnostic Substances)